Vendor qualification across multi-location groups
Pain management and physical medicine groups, especially those operating more than one Rochester-area location, generally centralize vendor approval at the group level rather than letting individual sites select suppliers independently. That centralized review usually asks for the same documentation set regardless of how many locations will eventually order.
Precision Biologics issues this documentation per lot, not as a blanket claim about the product line, since release testing results vary lot to lot.
Rochester
NPPES registry listings, primary taxonomy, retrieved 2026-10-27
144- Pain Medicine
- 49
- Physical Medicine & Rehabilitation
- 95
Opening and maintaining an NPI-verified account
Pain management practices set up a Precision Biologics account by confirming the NPI number associated with the practice and the individual placing orders. For group practices with multiple Rochester locations, each ordering location is generally tied back to the same verified account rather than requiring separate verification per site.
Account access to pricing and specification sheets is restricted to verified accounts.
Receiving shipments and keeping lot records
Cryopreserved Wharton's jelly and exosome formats ship overnight on dry ice in validated containers; lyophilized formats are shelf-stable and ship at ambient temperature. A clinic's front-desk or clinical staff should know which format is arriving on a given day, since cryopreserved shipments need prompt receiving and log-in, while lyophilized shipments do not carry the same time pressure.
Clinics are expected to track product use by lot number at the patient-record level, independent of how the supplier tracks the same lot internally.
Confirming regulatory posture before ordering
Pain management practices should have their medical director and counsel determine how a given product and intended use are classified, and should separately verify current licensing and scope-of-practice requirements with the New York medical board. Precision Biologics supplies the underlying documentation for that review but does not make the classification determination itself.
FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.
Frequently asked questions
Can a multi-location pain management group in Rochester use one account for all its sites?+
Yes. Account verification is tied to the group's NPI record, and ordering locations within that group are generally linked to the same verified account rather than re-verified individually.
What's the difference in receiving requirements between a cryopreserved and a lyophilized Wharton's jelly product?+
Cryopreserved products ship overnight on dry ice and need prompt receiving; lyophilized products are shelf-stable at ambient temperature and do not carry the same time-sensitive receiving window.
Who decides whether a product fits our practice's intended use in Rochester?+
That determination belongs to your practice's medical director and legal counsel, informed by documentation Precision Biologics provides and a review against current New York licensing requirements.